ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,076.04
1.31%
Dow Jones
38,534.60
0.77%
US Dollar vs MXN
16.9761
-0.96%
Brent Oil
87.535
1.30%
Bitcoin
66,818.95
-0.06%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Biogen Inc (BIIB)

  7. Biogen Inc (BIIB) Noticias

BIIB Biogen Inc

194.35
0.24 (0.12%)
Última actualización: 13:07:25
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Biogen Inc BIIB NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.24 0.12% 194.35 13:07:25
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
193.34 193.28 195.86 194.11
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
31/3/202418:30PRNUSEisai Completes Submission of LEQEMBI® (lecanemab-irmb)..
06/3/202406:30GLOBENew Biomarker Data Add Further Evidence Supporting the..
04/3/202415:15GLOBEBiogen Highlights New Data at the International Conference..
26/2/202418:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202406:00GLOBEBiogen’s QALSODY® (tofersen), the First Therapy to Treat..
22/2/202409:12EDGAR2Form 144 - Report of proposed sale of securities
21/2/202420:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202420:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202420:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202420:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202420:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202420:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202420:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202409:24EDGAR2Form 144 - Report of proposed sale of securities
20/2/202420:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202417:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202417:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202417:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202417:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202417:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202417:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202416:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202406:07EDGAR2Form 8-K - Current report
12/2/202418:11EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202418:07EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202415:06GLOBEBiogen Received European Commission Approval for SKYCLARYS®..
12/2/202410:10EDGAR2Form 144 - Report of proposed sale of securities
09/2/202419:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202419:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202419:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202419:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202419:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202419:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202419:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202419:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202418:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202418:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202417:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202409:44EDGAR2Form 144 - Report of proposed sale of securities
31/1/202416:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202416:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202416:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202416:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202416:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202416:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202416:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202413:27EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
19/12/202306:30GLOBECentralized Marketing Authorizations of Generic Versions of..
15/12/202308:05GLOBECHMP Issues Positive Opinion for Biogen’s SKYCLARYS®..
14/12/202305:30GLOBEZURZUVAE™ (zuranolone) CIV, a Landmark Oral Treatment for..

Su Consulta Reciente

NASDAQ
BIIB
Biogen
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados